Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

This Phase 1 trial reports on the safety, tolerability, pharmacokinetics, and pharmacodynamics of INCB099280 in participants with advanced solid tumors, includi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Cutaneous Squamous Cell Carcinoma
• Esophageal Squamous Cell Carcinoma
• Hepatocellular Carcinoma
• Merkel Cell Carcinoma
• Msi-h Dmmr Tumors
• Nasopharyngeal Carcinoma
• Urothelial Carcinoma

Drugs mentioned

• INCB099280 (INCB099280)

Snippet

Sponsor: Incyte Corporation | Conditions: Advanced Solid Tumor, MSI-H/dMMR Tumors | Phase 1 | Status: COMPLETED